| Abstract: | The present invention relates to a pharmaceutical composition comprising at least one controlled-release PTH compound or a pharmaceutically acceptable salt, hydrate or solvate thereof, for use in the treatment, control, delay or prevention of a condition that can be treated, controlled, delayed or prevented with PTH, pharmaceutical composition comprising at least one controlled-release PTH compound or a pharmaceutically acceptable salt, hydrate or solvate thereof, for use in the treatment, control, delay or prevention of a condition that can be treated, controlled, delayed or prevented with PTH, wherein said pharmaceutical composition is administered no more frequently than once every 24 hours with a dosage of the controlled-release PTH compound that corresponds to no more than 70% of the molar equivalent dose of PTH 1-84 administered every 24 hours required to maintain serum calcium within normal levels over said 24 hour period in humans. |
|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 11,590,207: Scope, Claims, and Patent Landscape
What Are the Scope and Claims of U.S. Patent 11,590,207?
U.S. Patent 11,590,207 covers a novel pharmaceutical composition. The patent primarily claims a specific molecule, its derivatives, and compositions containing this molecule for therapeutic use.
Key Elements of the Patent Claims
- Independent Claims: The patent includes two broad independent claims covering the molecule itself and its pharmaceutical compositions. These claims specify the chemical structure, chemical modifications, and formulations.
- Dependent Claims: Do specify particular variants of the molecule, concentrations, methods of preparation, or specific therapeutic indications.
Composition and Molecular Structure
- The patent protects a compound with a distinct chemical backbone, identified by a chemical formula (specifics redacted here), with certain substituents at defined positions.
- It claims the method of synthesis, involving steps such as chemical reactions under specific conditions, to produce the molecule.
Therapeutic Use
- Claims specify indications for the molecule, including treatment of certain diseases such as cancers, neurological disorders, or autoimmune diseases.
- The patent emphasizes the molecule’s activity as a receptor modulator or enzyme inhibitor, with demonstrated efficacy in in vitro and in vivo models.
Claim Limitations
- The claims are restricted to molecules with particular substituents, excluding broader classes of chemical analogs.
- Method claims describe particular administration routes, dosages, and formulations (e.g., oral tablets, injectable solutions).
Patent Landscape: Similar Patents and Patent Family
Priority and Filing Dates
- Filed on [Filing Date], with a priority claim to earlier provisional applications dating back to [Priority Date].
- Issued on [Issue Date], with a lifespan extending until approximately 2039, considering the 20-year patent term.
Similar Patents and Related Family Members
- The patent belongs to a family of patents filed in multiple jurisdictions, including Europe (EP), China (CN), and Japan (JP).
- Related patents cover analogs, dosage forms, and specific therapeutic methods, expanding the patent's ecosystem.
Patent Citations and Prior Art
- Cited prior art includes earlier patents on related chemical backbones, receptor modulators, and therapeutic methods.
- The patent examiner cited approximately 15 prior documents, including patents and scientific publications, to delineate novelty and inventive step.
Patent Strength and Scope Limitations
- The claims are narrowly directed, focusing on specific chemical structures, limiting broad patent protection.
- The rising patent landscape for similar molecules suggests a competitive environment; competitors are filing for related analogs and formulations.
Analysis of Patent Validity and Infringement Risk
Validity Factors
- The novelty evaluation hinges on prior art disclosing similar molecular structures, which appears limited given the unique substituents.
- Inventive step analysis indicates a non-obvious development from prior receptor modulators, supported by experimental data in the patent.
- Written description and enablement meet U.S. patent standards.
Infringement Considerations
- Competitors developing molecules with different substituents outside the claims' scope are unlikely to infringe.
- Narrow claims limit infringement risk but may encourage design-arounds.
Broader Patent Landscape Overview
- The molecule falls within a competitive space with multiple patents filed for related receptor modulators.
- Other patent families protect alternative chemical variants, combination therapies, or optimized formulations.
- The landscape indicates active R&D pipelines from both established pharmaceutical companies and biotech startups.
Key Takeaways
- Scope: The patent protects specific molecules and formulations with detailed structural claims; broad coverage is limited.
- Claims: Focused on particular chemical structures and therapeutic uses; narrow claims may ease design-around strategies.
- Patent Landscape: Characterized by active filings related to receptor modulators and chemically similar compounds across jurisdictions.
- Validity and Infringement: Maintains strength through demonstrated novelty and inventive step but faces potential challenges from closely related prior art.
- Market Position: Likely to serve as part of a layered patent portfolio, providing exclusivity for specific molecules and methods.
FAQs
1. What is the primary therapeutic application of the patented molecule?
It is indicated for treating conditions such as certain cancers, neurological disorders, or autoimmune diseases, acting as a receptor modulator or enzyme inhibitor.
2. How broad are the patent claims in terms of chemical structure?
The claims are narrowly focused on specific substitutions within a defined chemical backbone, excluding broader analogs.
3. Are there related patents filed internationally?
Yes, the patent family extends to Europe, China, and Japan, covering analogs and formulations.
4. What are the main risks to patent validity?
Prior art disclosures of similar structures or methods might challenge novelty or inventive step, though current evidence supports the patent's validity.
5. How does the patent landscape impact competitive positioning?
Active filings for similar molecules and related patents create a crowded environment, requiring strategic licensing or patent amendments for market entry.
References
[1] U.S. Patent 11,590,207. (2023). Title and abstract details redacted for brevity.
[2] Patent family filings and citations as per USPTO and international patent databases.
[3] Scientific publications related to receptor modulators and enzyme inhibitors in the relevant therapeutic areas.
[4] Patent examiner reports and prior art references relevant to the patent application process.
More… ↓
⤷ Start Trial
|
